The results showed that immunoreactivities with anti-sPmel17 and anti-FHL2 antibodies almost completely disappeared in the vitiliginous lesions; however, the restoration of immunostaining using those same antibodies was found in the repigmented skins from the same vitiligo patients (Figure 6(a)). This evidence concerns the gene FHL2 and vitiligo.